LFPI.US LifePoint Inc

Healthcare Health Care Providers & Services USA Stocks
0.0036 USD
Close of Jun 12, 2026
Market cap
USD 146K
P/E
-
P/B
0.00x
ROE
-178.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Dec 2004.

Is LFPI.US undervalued?

Graham number

The Graham number of LifePoint Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

LifePoint Inc fundamental analysis

No fundamental analysis for LifePoint Inc yet.

LifePoint Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About LifePoint Inc

LifePoint, Inc. develops, manufactures, and sells IMPACT Test System, a diagnostic testing and screening device. It serves workplaces, ambulances, pharmacies, law enforcements, and home health care markets. LifePoint, Inc. was formerly known as US Drug Testing, Inc. and changed its name to LifePoint, Inc. in February 1998. The company was incorporated in 1992 and is based in Ontario, California.

Full company profile